Temat: "Thyrotropin" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Casein Kinase 1α as a Novel Factor Affects Thyrotropin Synthesis via PKC/ERK/CREB Signaling.
Autorzy:: Wang B; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.
Zhang J; Institute of Reproduction and Metabolism, Yangzhou University, Yangzhou 225009, China.; Joint International Research Laboratory of Agriculture and Agri-Product Safety, The Ministry of Education of China, Yangzhou University, Yangzhou 225009, China.
Zhang D; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.; Institute of Reproduction and Metabolism, Yangzhou University, Yangzhou 225009, China.
Lu C; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.
Liu H; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.
Gao Q; Institute of Reproduction and Metabolism, Yangzhou University, Yangzhou 225009, China.
Niu T; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.
Yin M; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.
Cui S; College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.; Institute of Reproduction and Metabolism, Yangzhou University, Yangzhou 225009, China.; Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Apr 11; Vol. 24 (8). Date of Electronic Publication: 2023 Apr 11.
Typ publikacji:: Journal Article
MeSH Terms:: Casein Kinases*/metabolism
Extracellular Signal-Regulated MAP Kinases*/metabolism
Thyrotropin*/metabolism
Animals ; Mice ; Pituitary Gland/metabolism ; Thyrotropin-Releasing Hormone/metabolism ; Thyroxine/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Effect of withdrawal of thyroid hormones versus administration of recombinant human thyroid-stimulating hormone on renal function in thyroid cancer patients.
Autorzy:: An YS; Department of Nuclear Medicine and Molecular Imaging, Ajou University School of Medicine, Suwon, Korea. .
Lee J; Department of Surgery, Ajou University School of Medicine, Suwon, Korea.
Kim HK; Department of Surgery, Ajou University School of Medicine, Suwon, Korea.
Lee SJ; Department of Nuclear Medicine and Molecular Imaging, Ajou University School of Medicine, Suwon, Korea.
Yoon JK; Department of Nuclear Medicine and Molecular Imaging, Ajou University School of Medicine, Suwon, Korea.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Jan 05; Vol. 13 (1), pp. 206. Date of Electronic Publication: 2023 Jan 05.
Typ publikacji:: Journal Article
MeSH Terms:: Thyrotropin Alfa*
Thyroid Neoplasms*/drug therapy
Thyroid Neoplasms*/surgery
Humans ; Thyrotropin ; Thyroid Hormones ; Kidney/physiology ; Recombinant Proteins/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Comparison of the correlation between serum autoantibodies against aldehyde dehydrogenase 2 and thyrotropin receptor in patients with Graves' ophthalmopathy.
Autorzy:: Lin CC; Department of Ophthalmology, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.; Department of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Chiu LW; Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Lee PY; Department of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chen KJ; Department of Ophthalmology, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.
Cheng KC; Department of Ophthalmology, Kaohsiung Municipal Siaogang Hospital, Kaohsiung, Taiwan.; Department of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Department of Ophthalmology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Pokaż więcej
Źródło:: Indian journal of ophthalmology [Indian J Ophthalmol] 2024 Feb 01; Vol. 72 (2), pp. 298-299. Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Graves Ophthalmopathy*/diagnosis
Receptors, Thyrotropin*
Humans ; Aldehyde Dehydrogenase ; Autoantibodies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Novel recombinant human thyroid-stimulating hormone in aiding postoperative assessment of patients with differentiated thyroid cancer-phase I/II study.
Autorzy:: Lin YS; Department of Nuclear Medicine, Dongcheng District, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Sciences & PUMC, No.1 Shuaifuyuan, Wangfujing St, Beijing, 100730, China. .; State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China. .; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China. .
Yang H; Department of Nuclear Medicine, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Li XY; Department of General Surgery, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Sciences & PUMC, Beijing, China.
Wu LQ; Clinical Research Department, Suzhou Zelgen Biopharmaceuticals Co., Ltd, Suzhou, China.
Xu JG; Biological R&D Department, Suzhou Zelgen Biopharmaceuticals Co., Ltd, Suzhou, China.
Yang AM; Department of Nuclear Medicine, The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China.
Gao ZR; Department of Nuclear Medicine, Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.; Key Laboratory of Biological Targeted Therapy, the Ministry of Education, Wuhan, China.
Ding Y; Department of Nuclear Medicine, The Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.
Zhang YQ; Department of Nuclear Medicine, Dongcheng District, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Sciences & PUMC, No.1 Shuaifuyuan, Wangfujing St, Beijing, 100730, China.; State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China.; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.
Chen K; Department of Nuclear Medicine, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Mu ZZ; Department of Nuclear Medicine, Dongcheng District, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Sciences & PUMC, No.1 Shuaifuyuan, Wangfujing St, Beijing, 100730, China.; State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China.; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.
Jia JM; Department of Nuclear Medicine, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Niu N; Department of Nuclear Medicine, Dongcheng District, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Sciences & PUMC, No.1 Shuaifuyuan, Wangfujing St, Beijing, 100730, China.; State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China.; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.
Sun D; Department of Nuclear Medicine, Dongcheng District, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Sciences & PUMC, No.1 Shuaifuyuan, Wangfujing St, Beijing, 100730, China.; State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China.; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.
Zhang X; Department of Nuclear Medicine, Dongcheng District, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Sciences & PUMC, No.1 Shuaifuyuan, Wangfujing St, Beijing, 100730, China.; State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China.; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.
Zhang SQ; Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China.
Geng QQ; Department of Nuclear Medicine, The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China.
Zhang YJ; Department of Nuclear Medicine, Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.; Key Laboratory of Biological Targeted Therapy, the Ministry of Education, Wuhan, China.
Chen FN; Department of Nuclear Medicine, The Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.
He BX; Phase I Clinical Research Center, Zhengzhou University Affiliated Cancer Hospital, Zhengzhou, China.; Pokaż więcej
Źródło:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Oct; Vol. 49 (12), pp. 4171-4181. Date of Electronic Publication: 2022 Jul 04.
Typ publikacji:: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
MeSH Terms:: Adenocarcinoma*
Thyroid Neoplasms*/radiotherapy
Thyroid Neoplasms*/surgery
Thyrotropin Alfa*/adverse effects
Humans ; Iodine Radioisotopes/adverse effects ; Quality of Life ; Thyroid Hormones ; Thyrotropin/therapeutic use ; Thyroxine ; Tomography, X-Ray Computed

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Development of Low-Molecular-Weight Allosteric Agonist of Thyroid-Stimulating Hormone Receptor with Thyroidogenic Activity.
Autorzy:: Bakhtyukov AA; Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia.
Derkach KV; Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia.
Fokina EA; Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia.
Sorokoumov VN; Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia.; Institute of Chemistry, St. Petersburg State University, St. Petersburg, Russia.
Zakharova IO; Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia.
Bayunova LV; Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia.
Shpakov AO; Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia. alex_.; Pokaż więcej
Źródło:: Doklady. Biochemistry and biophysics [Dokl Biochem Biophys] 2022 Apr; Vol. 503 (1), pp. 67-70. Date of Electronic Publication: 2022 May 10.
Typ publikacji:: Journal Article
MeSH Terms:: Hypothyroidism*/chemically induced
Hypothyroidism*/drug therapy
Receptors, Thyrotropin*
Animals ; Rats ; Receptors, G-Protein-Coupled ; Thyrotropin/pharmacology ; Thyroxine

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Observational study of diagnosis and management in adult primary hypothyroidism in southwest of Sweden.
Autorzy:: Bengtsson E; Ullareds Vårdcentral, Region Halland, Sweden.
Funkquist A; Halland Hospital, Region Halland, Sweden.
Agvall B; Department of Research and Development, Halmstad, Region Halland, Sweden.; Pokaż więcej
Źródło:: Scandinavian journal of primary health care [Scand J Prim Health Care] 2023 Sep; Vol. 41 (3), pp. 189-195. Date of Electronic Publication: 2023 May 24.
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: Thyrotropin*/therapeutic use
Hypothyroidism*/diagnosis
Hypothyroidism*/drug therapy
Adult ; Humans ; Adolescent ; Sweden ; Thyroxine/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Management of Subclinical Hypothyroidism: A Focus on Proven Health Effects in the 2023 Korean Thyroid Association Guidelines.
Autorzy:: Ku EJ; Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul.
Yoo WS; Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea.
Chung HK; Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea.; Pokaż więcej
Źródło:: Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2023 Aug; Vol. 38 (4), pp. 381-391. Date of Electronic Publication: 2023 Aug 08.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Thyrotropin*
Hypothyroidism*/drug therapy
Adult ; Humans ; Aged ; Thyroxine/therapeutic use ; Republic of Korea/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Association between anti-thyroid peroxidase antibody and thyroid stimulating hormone: a cross-sectional study.
Autorzy:: Shimizu Y; Department of General Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto Nagasaki-shi, Nagsaki, 852-8523, Japan. .; Epiedmiology Section, Division of Public Health, Osaka Institute of Public Health, Osaka, 537-0025, Japan. .
Matsuyama M; Division of Strategic Collaborative Research, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, 852-8523, Japan.
Noguchi Y; Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, 852-8523, Japan.
Takada M; Epiedmiology Section, Division of Public Health, Osaka Institute of Public Health, Osaka, 537-0025, Japan.
Kawashiri SY; Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, 852-8523, Japan.; Leading Medical Research Core Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, 852-8523, Japan.
Fukui S; Department of General Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto Nagasaki-shi, Nagsaki, 852-8523, Japan.
Nakamichi S; Department of General Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto Nagasaki-shi, Nagsaki, 852-8523, Japan.; Nagasaki University Health Center, Nagasaki, 852-8521, Japan.
Nagata Y; Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, 852-8523, Japan.; Leading Medical Research Core Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, 852-8523, Japan.
Maeda T; Department of General Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto Nagasaki-shi, Nagsaki, 852-8523, Japan.; Leading Medical Research Core Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, 852-8523, Japan.
Hayashida N; Division of Strategic Collaborative Research, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, 852-8523, Japan.; Leading Medical Research Core Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, 852-8523, Japan.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Sep 01; Vol. 13 (1), pp. 14358. Date of Electronic Publication: 2023 Sep 01.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Thyrotropin*
Hypothyroidism*
Humans ; Cross-Sectional Studies ; Peroxidases

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients.
Autorzy:: Campennì A; Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, Via Consolare Valeria nr.1, 98125, Messina, Italy. .
Ruggeri RM; Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Siracusa M; Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, Via Consolare Valeria nr.1, 98125, Messina, Italy.
Comis AD; Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, Via Consolare Valeria nr.1, 98125, Messina, Italy.
Romano D; Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, Via Consolare Valeria nr.1, 98125, Messina, Italy.
Vento A; Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, Via Consolare Valeria nr.1, 98125, Messina, Italy.
Lanzafame H; Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, Via Consolare Valeria nr.1, 98125, Messina, Italy.
Capoccetti F; Service Department Macerata Hospital, ASUR Marche AV3, Nuclear Medicine Unit, Macerata, Italy.
Alibrandi A; Unit of Statistical and Mathematical Sciences, Department of Economics, University of Messina, Messina, Italy.
Baldari S; Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, Via Consolare Valeria nr.1, 98125, Messina, Italy.
Giovanella L; Clinic for Nuclear Medicine and Competence Centre for Thyroid Diseases, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Clinic for Nuclear Medicine, University Hospital and University of Zurich, Zurich, Switzerland.; Pokaż więcej
Źródło:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Jul; Vol. 48 (8), pp. 2466-2475. Date of Electronic Publication: 2021 Jan 08.
Typ publikacji:: Journal Article
MeSH Terms:: Thyroid Neoplasms*/surgery
Thyrotropin Alfa*
Humans ; Iodine Radioisotopes ; Thyroglobulin ; Thyroidectomy ; Thyrotropin

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: New Efforts to Demonstrate the Successful Use of TRH as a Therapeutic Agent.
Autorzy:: Alvarez-Salas E; Laboratorio de Neurofisiología Molecular, Dirección de Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calzada México-Xochimilco 101, San Lorenzo Huipulco, Tlalpan, Mexico City CP 14370, Mexico.
García-Luna C; Laboratorio de Neurofisiología Molecular, Dirección de Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calzada México-Xochimilco 101, San Lorenzo Huipulco, Tlalpan, Mexico City CP 14370, Mexico.
de Gortari P; Laboratorio de Neurofisiología Molecular, Dirección de Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calzada México-Xochimilco 101, San Lorenzo Huipulco, Tlalpan, Mexico City CP 14370, Mexico.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jul 04; Vol. 24 (13). Date of Electronic Publication: 2023 Jul 04.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Thyrotropin-Releasing Hormone*/therapeutic use
Thyrotropin-Releasing Hormone*/metabolism
Brain*/metabolism
Animals ; Humans ; Thyroid Gland/metabolism ; Peptides/metabolism ; Thyroid Hormones/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Thyrotropin"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji